Tempus
AI-powered precision medicine platform connecting genomic data to clinical outcomes for cancer and complex disease.
What it does
Tempus is an AI-driven precision medicine company that combines genomic sequencing, clinical data, and AI to help physicians make better treatment decisions for cancer and complex disease. Its platform ingests molecular profiling data (genomic, transcriptomic, proteomic) alongside structured and unstructured clinical records to identify treatment patterns, match patients to clinical trials, and surface insights about which therapies work best for specific molecular profiles. Tempus's AI capabilities include natural language processing that extracts structured data from physician notes, predictive models that identify patients likely to respond to specific treatments, and a data licensing business that applies its clinical AI to pharmaceutical research and drug development.
Why AI-NATIVE
Tempus is AI-native - molecular data integration with clinical AI for treatment matching, patient-trial matching, and predictive response models are the core product architecture from the ground up.
Best for
Academic medical centers, cancer centers, and health systems use Tempus for precision oncology - AI connecting molecular profiles to clinical evidence to inform treatment decisions and identify clinical trial eligibility.
Limitations
Tempus is primarily built for oncology use cases — health systems needing AI for non-cancer disease areas have a more limited applicable feature set.
Genomic testing reimbursement remains complex and inconsistent — health systems must navigate payer policies for molecular profiling, which affects adoption at the patient level.
Integrating genomic and clinical data at the scale Tempus requires demands rigorous data governance, consent management, and HIPAA compliance — implementation is not trivial for health systems with fragmented EHR environments.
Alternatives by segment
| If you need… | Consider instead |
|---|---|
| Clinical AI broadly | Innovaccer |
| Genomic data platform | Benchling |
| Drug discovery AI | Insilico Medicine |
Tempus does not publish standard pricing. Genomic testing services are billed per test. Data licensing and clinical AI platform contracts are enterprise-negotiated. Enterprise health system partnerships typically start in the seven-figure range.
